The results of this study indicate that the recombinant envelope protein obtained from the SARS-CoV-2 Ank-1 strain can stimulate both humoral and cellular immune responses that are essential for controlling the dissemination of infection and to inhibiting the entry of the virus. This evidence concerns the gene ERVW-1 and infection.